If the U.S. goes ahead with its tariffs, we can expect tariffs on drugs and Canada to retaliate with similar measures, warns pharmacy industry expert Bertrand Bolduc.
As physicians, we often focus on the tangible—lab results, diagnostic criteria, treatment plans. But sometimes, the most profound impacts we make aren’t in the exam room or through clinical interventions.
Pharmacists are already in the trenches, armed with drug knowledge, a shocking tolerance for paperwork and the ability to spot a fake online pharmacy from a mile away (looking at you, “Bob’s Discount Viagra Emporium”).
So why aren’t we letting pharmacists do more?
In Walkerton, Ont., a new family medicine practice accepting patients drew a line of hundreds of people, some waiting in the cold as early as 2 a.m. One person described securing a family doctor as ‘winning the lottery.’
As misinformation and disinformation run rampant, questioning the utility of peer review is sure to raise eyebrows, blood pressure and tempers among academics and healthcare professionals alike.
